Video

Giving a Voice to Patients With GI Cancers

Author(s):

Martha Raymond

Martha Raymond, founder and CEO of the Raymond Foundation, discusses how her organization helps to provide a voice for patients with gastrointestinal (GI) cancers.

Martha Raymond, founder and CEO of the Raymond Foundation, discusses how her organization helps to provide a voice for patients with gastrointestinal (GI) cancers.

After losing both her parents to colon cancer, Raymond founded the Raymond Foundation to provide outreach and support to patients with the disease.

Now, the Raymond Foundation serves patients with all kinds of GI cancers by going into the communities and talking to patients and caregivers to better understand what needs they feel are being unmet. The foundation then takes that information to universities, hospitals and medical centers, where larger programs can be established to address these needs.

Related Videos
Adolescent and Young Adult Cancer Awareness Week sheds light on the financial hardships young cancer survivors face, including debt and limited assistance.
CURE spoke with Dr. William C. Huang about what kind of team may be required to treat a patient with metastatic kidney cancer.
Image of woman.
Image of woman.
Image of woman.
Image of man wearing baseball cap backwards.
Image of smiling doctor.
Registered nurse Patricia Jakel emphasizes the importance of educating patients on evolving breast cancer research and the need for routine screenings.
Dr. Debu Tripathy highlights the importance of staying informed on breast cancer advancements and how this empowers patients to make informed decisions.
Image od grey haired Doctor.
Related Content
Artificial Intelligence Enhances Polyp Detection in Colorectal Cancer
March 6th 2025

Artificial Intelligence Enhances Polyp Detection in Colorectal Cancer

Ryan Scott
Artificial intelligence aids in polyp detection, enhancing colonoscopy effectiveness and reducing the risk of colorectal cancer progression in patients.
Identifying and Addressing the Barriers to Clinical Trial Access
January 21st 2021

Identifying and Addressing the Barriers to Clinical Trial Access

Jessica Skarzynski
This week on the “CURE® Talks Cancer” podcast, we spoke with Martha Raymond, of The Raymond Foundation, about how providers can ensure patient safety to increase trial enrollment during the COVID-19 pandemic, and what she and her colleagues are doing to provide better trial access to all patients with cancer.
Image of doctor with brown hair.
February 25th 2025

Some KRAS Mutations Associated With Worse Outcomes in Pancreatic Cancer

Dr. Vaia Florou
In patients with pancreatic ductal adenocarcinoma, KRAS G12D and G12V mutations hare associated with worse patient outcomes, researchers have found.
Site Logo
November 15th 2018

The Ins and Outs of Cancer Caregiving

Brielle Benyon
Two women discuss their experience in cancer caregiving, while giving advice to others.
Dr. Robert Jones is a professor of Clinical Cancer Research at The University of Glasgow School of Cancer Sciences, in Scotland.
February 15th 2025

Bavencio Has Efficacy in The Real-World Treatment of Urothelial Cancer

Dr. Robert Jones
Following treatment with Bavencio, patients with urothelial cancer lived for 17 months and their cancer remained stable for nine months.
Image of man with black hair.
February 3rd 2025

Rybrevant Alone and in Combo With Chemo is Efficacious in Wildtype+ mCRC

Ryan Scott
Dr. Filippo Pietrantonio discusses OrigAMI-1 trial data which assessed Rybrevant in mutated, wild-type, non-HER2-amplified metastatic colorectal cancer.